Zentalis Pharma Stock (NASDAQ: ZNTL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 808.707K |
Day Range | - - - |
52 Wk Range | 9.560 - 31.460 |
Market Cap | $890.506M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 47.34% |
Days to Cover | 22.95 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Zentalis Pharma (NASDAQ: ZNTL) through any online brokerage.
Other companies in Zentalis Pharma’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Centessa Pharmaceuticals (NASDAQ:CNTA) and Immatics (NASDAQ:IMTX).
The latest price target for Zentalis Pharma (NASDAQ: ZNTL) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 40.00 expecting ZNTL to rise to within 12 months (a possible 218.98% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Zentalis Pharma (NASDAQ: ZNTL) is $12.54 last updated May 10, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Zentalis Pharma.
Zentalis Pharma’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Zentalis Pharma.
Zentalis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.